Medoxa

GIF decision: Withdrawal from market, Marketing prohibition

What does this decision mean?

• Wycofanie z obrotu — Some of the products covered by the decision were withdrawn from the market — please return them to the pharmacy/distributor.
• Zakaz wprowadzania — Selected batches are subject to a marketing prohibition — the product cannot be distributed to pharmacies.

The National Medicines Institute reported an out-of-specification result for the parameter "appearance": tablets were non-homogeneous and some had an additional score line; during packaging, thicker and broken tablets were also found. Potential effects: improper dosing of the drug, reduced efficacy or increased adverse reactions.

Download the app and stay informed

Get instant notifications about recalled products and protect your family.

App Store Google Play

Risk Level

Medium

Manufacturer

Zakłady Farmaceutyczne POLPHARMA S.A.

Batch Number

E0486E, E0486B

Notice Date

11.03.2026

What to do if you have this product?

A recall means the product may be unsafe. Here is what to do if you have it at home.

1

Do not eat or use the product

Stop using or consuming it immediately and keep it out of reach of children.
2

Check the batch number and expiry date

Compare the batch/lot number and the best-before or expiry date with the details in the alert — sometimes only specific batches are affected.
3

Return it to the shop

You can take the product back to the shop where you bought it. For a safety recall a refund is due even without a receipt.
4

Get help and report it

If you feel unwell after using the product, contact a doctor. You can also report the case to the relevant authority — GIS, GIF or UOKiK.

General guidance for recalled products in Poland. Always follow the specific instructions in the official alert and from the manufacturer or retailer.

Medoxa

What to do if you have this product?

Other Notices

Imuldosa

Loperamid APTEO MED

Tullex

Travoprost + Timolol Medical Valley

Kidofen